PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Finance » Dow Plummets 230 Points Amid Fears of Trade War with China

Dow Plummets 230 Points Amid Fears of Trade War with China

by PublicWire
August 2, 2019
in Finance
Reading Time: 2 mins read
0

As talks continue between the US and China, there is another new proposed tariff on the trade with China that amounts to nearly $300 billion dollars. The Dow Jones industrial Average has slipped by 229 points today.

The proposed 10% tariff comes in to effect next year, this is a separate tariff and will not be covered by the earlier imposed tariffs. With fears of a recession next year from soaring prices on imports, both the Nasdaq and Dow Jones are set close at the lowest rate of 2019.

The true damage of this trade war could potentially disrupt supply chains in nearly every global market.

So when does it all go in to effect?

If there is no agreement on making the prices more stable, September 1 2019. Many industry leaders are divided on the potential split, Goldman Sachs predicts that a recession will occur from this proposed tariff increase next year but Gregory Draco (chief U.S. economist of Oxford Economics) .

In previous recent trends, President Trump has proposed tariffs before but have called them off by making agreements with China’s Foreign Ministry.

The key point to take from this potential trade war is who will face the cost? Will businesses cover the cost increases, just half of the increase or will they past the cost on to the consumer?

Tags: ChinaDow JonesPresident TrumpTrade WarUnited States
Previous Post

Curaleaf Holdings Acquires Grassroots Cannabis

Next Post

The FDA Issues a Letter To Curaleaf Warning it Violated the Food, Drug and Cosmetic Act

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Finance

US stocks extend gains on signs of steadying inflation

August 11, 2022
0
Finance

Western sanctions have had ‘limited impact’ on Russian oil output, says IEA

August 11, 2022
0
Finance

Zurich chief says excess capital could fund deals after $1.9bn share buyback

August 11, 2022
0
Finance

Two former JPMorgan metals traders convicted at spoofing trial

August 10, 2022
0
Finance

Live news updates: China locks down major manufacturing hub as Covid-19 cases rise nationally

August 10, 2022
0
Finance

Hungary oil group pays fee to restart flow of Russian oil through Ukraine

August 10, 2022
0
Next Post

The FDA Issues a Letter To Curaleaf Warning it Violated the Food, Drug and Cosmetic Act

Please login to join discussion

Subscribe To Our Newsletter

Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 PublicWire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 PublicWire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.